44 unchanged sentences
Rule 10b5-1 Plan Elections
+Added: Parkinson , a member of our Board of Directors , entered into a Rule 10b5-1 trading arrangement on November 6, 2025 .
+Added: Parkinson's 10b5-1 Plan provides for the potential sale of up to 400 shares of the Company's common stock between February 9, 2026 and October 15, 2026 .
Blouin , a member of our Board of Directors , entered into a Rule 10b5-1 trading arrangement on November 7, 2025 .
−Removed: Blouin's 10b5-1 Plan provides for the sale of up to 450 shares of the Company's common stock between February 11, 2025 and November 11, 2025 .
−Removed: Snapper , Chief Financial Officer, Executive Vice President, and Director , entered into a Rule 10b5-1 trading arrangement on November 15, 2024 .
−Removed: Snapper's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,618 shares of the Company's common stock between February 18, 2025 and July 28, 2025 .
+Added: Blouin's 10b5-1 Plan provides for the potential sale of up to 375 shares of the Company's common stock between February 9, 2026 and November 5, 2026 .
These Rule 10b5-1 trading arrangements were entered into during open trading windows and are intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) under the Securities Exchange Act of 1934, as amended, and the Company's policies regarding transactions in Company securities.
30 unchanged sentences
10-Q 001-33757 3.2 12/21/2007
+Added: Exhibit File Exhibit Filing Filed
+Added: Exhibit Description* Form No.
+Added: Date Herewith
Amendment to the Amended and Restated Bylaws, dated August 5, 2014 8-K 001-33757 3.2 8/8/2014
+Added: Amendment to the Amended and Restated Bylaws of The Ensign Group, Inc., dated March 15, 2024 10-Q 001-33757 3.4 4/29/2025
Description of the Common stock of The Ensign Group, Inc.
22 unchanged sentences
participate in the Washington Medicaid program S-1 333-142897 10.52 10/19/2007
−Removed: Exhibit File Exhibit Filing Filed
−Removed: Exhibit Description* Form No.
−Removed: Date Herewith
Form of Provider Agreement for Medicaid and UMAP pursuant to which certain subsidiaries of The Ensign Group, Inc.
10 unchanged sentences
8-K 001-33757 10.1 6/5/2014
+Added: Exhibit File Exhibit Filing Filed
+Added: Exhibit Description* Form No.
+Added: Date Herewith
Form of Guaranty of Master Lease by The Ensign Group, Inc.
18 unchanged sentences
Deferred Compensation Plan 10-K 001-33757 10.2 2/3/2021
−Removed: Exhibit File Exhibit Filing Filed
−Removed: Exhibit Description* Form No.
−Removed: Date Herewith
First Amendment to Third Amended and Restated Credit Agreement, dated as of February 8, 2022, by and among The Ensign Group, Inc., Standard Bearer Healthcare REIT, Inc., Truist Bank (as successor by merger to SunTrust Bank), as administrative agent, and the lenders party thereto 10-K 001-33757 10.1 2/9/2022
3 unchanged sentences
+ The Ensign Group, Inc.
−Removed: 2022 Omnibus Incentive Plan DEF 14A 001-33757 A 4/14/2022
+Added: Amended and Restated Omnibus Incentive Plan
+Added: 001-33757 4.5 6/26/2025
+ Form of Omnibus Incentive Plan Notice of Grant of Stock Options;
−Removed: and form of Non-Incentive Stock Option Award Terms and Conditions 10-K 001-33757 10.32 2/2/2023
−Removed: + Form of 2022 Omnibus Incentive Plan Restricted Stock Agreement 10-K 001-33757 10.33 2/2/2023
+Added: and form of Non-Incentive Stock Option Award Terms and Conditions
+Added: 10-K 001-33757 10.2 2/2/2023
+Added: + Form of Omnibus Incentive Plan Restricted Stock Agreement
+Added: 10-K 001-33757 10.3 2/2/2023
+Added: + Form of Notice of Restricted Stock Award to the Amended and Restated Omnibus Incentive Plan of the Company;
+Added: and Terms and Conditions of Restricted Stock Awards pursuant to the Amended and Restated Omnibus Incentive Plan of the Company
+Added: 10.1 7/24/2025
+Added: Exhibit File Exhibit Filing Filed
+Added: Exhibit Description* Form No.
+Added: Date Herewith
+Added: + Form of Notice of Non-Incentive Stock Option Award to the Amended and Restated Omnibus Incentive Plan of the Company ;
+Added: and Terms and Conditions of Non-Incentive Stock Option Awards to the Amended and Restated Omnibus Incentive Plan of the Company
+Added: 10.2 7/24/2025
Annual Report to Security Holders
−Removed: Statement of Company Policy Regarding Insider Trading X
+Added: Statement of Company Policy Regarding Insider Trading 10-K 001-33757 19.1 2/5/2025
Addendum to Statement of Company Policy Regarding Insider Trading
+Added: 10-K 001-33757 19.2 2/5/2025
Subsidiaries of The Ensign Group, Inc., as amended X
18 unchanged sentences
Signature Title Date
−Removed: PORT Chief Executive Officer and Director (principal executive officer) February 5, 2025
+Added: PORT Chief Executive Officer and Chairman of the Board (principal executive officer) February 4, 2026
/s/ SUZANNE D.
1 unchanged sentence
February 4, 2026
−Removed: /s/ CHRISTOPHER R.
−Removed: CHRISTENSEN Executive Chairman and Chairman of the Board February 5, 2025
−Removed: Christopher R.
+Added: SHAW Director February 4, 2026
+Added: SMITH Director February 4, 2026
BLOUIN Director February 4, 2026
ABBOTT Director February 4, 2026
−Removed: SHAW Director February 5, 2025
AGWUNOBI Director February 4, 2026
−Removed: SMITH Director February 5, 2025
PARKINSON Director February 4, 2026
+Added: /s/ MARIVIC UYCHIAT PISON
+Added: Vice President of Clinical Services and Director
+Added: February 4, 2026
+Added: Marivic Uychiat Pison
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.